Sign in

CIK 0001723128

  • Large accelerated filer

Amneal Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 908-947-3120
Former names
Atlas Holdings, Inc.
  1. 4 Shares withheld for taxes Executive Vice President gave up 8,353 shares (to pay taxes)
  2. 4 Option exercise Executive Vice President & CFO acquired 87,719 shares (option exercise)
  3. 4 Shares withheld for taxes Executive Vice President gave up 13,237 shares (to pay taxes)
  4. 4 Shares withheld for taxes Executive Vice President gave up 12,512 shares (to pay taxes)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise Executive Vice President & CFO acquired 36,197 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Shares withheld for taxes Executive Vice President gave up 21,925 shares (to pay taxes)
  10. 4 Shares withheld for taxes Executive Vice President gave up 11,107 shares (to pay taxes)
  11. 4 Shares withheld for taxes Executive Vice President gave up 11,695 shares (to pay taxes)
  12. 4 Shares withheld for taxes Executive Vice President gave up 16,434 shares (to pay taxes)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 50,000 shares at $4.21 ($210,500)
  16. 4 Open-market buy President & Co-CEO bought 150,000 shares at an average $4.17 ($625,500)
  17. 4 Open-market buy Co-CEO bought 150,000 shares at an average $4.17 ($625,500)
  18. 4 Open-market sale Executive Vice President sold 2,000 shares at $3.95 ($7,900)
  19. 4 Open-market sale Executive Vice President sold 1,500 shares at $4.10 ($6,150)
  20. 4 Shares withheld for taxes Executive Vice President gave up 11,583 shares (to pay taxes)

Page 9 of 18 · 351 filings